Patients & Families
Reimagining the future for
RARE NEUROLOGICAL DISEASES.
Neurogene is focused on developing life-changing genetic medicines for patients and their families affected by rare, devastating neurological diseases.
Neurogene Announces EMA Grants Orphan Drug Designation to CLN5 Batten Disease Gene Therapy